Trial Profile
A Retrospective Chart Review of BOTOX and Xeomin for the Treatment of Cervical Dystonia and Blepharospasm
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Torticollis
- Focus Therapeutic Use
- Sponsors Allergan
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Mar 2013 New trial record